COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 728: Articles 7271-7280  | Next

Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology
Hemmi, T., Ainai, A., Hashiguchi, T., Tobiume, M., Kanno, T., Iwata-Yoshikawa, N., Iida, S., Sato, Y., Miyamoto, S., Ueno, A., Sano, K., Saito, S., Shiwa-Sudo, N., Nagata, N., Tamura, K., Suzuki, R., Hasegawa, H., Suzuki, T.
10.1101/2022.05.24.493348 — Posted: 2022-05-25
Evaluation of triage checklist for mild COVID-19 outpatients in predicting subsequent emergency department visits and hospitalization during isolation period
Tanaka, Y., Yamamoto, K., Morimoto, S., Nabeshima, T., Matsushima, K., Ishimoto, H., Ashizawa, N., Hirayama, T., Takeda, K., Gyotoku, H., Iwanaga, N., Takemoto, S., Fukahori, S., Takazono, T., Yamaguchi, H., Kido, T., Sakamoto, N., Hosogaya, N., Akabame, S., Sugimoto, T., Yamanashi, H., Matsui, K., Izumida, M., Fujita, A., Tashiro, M., Tanaka, T., Ariyoshi, K., Furumoto, A., Morita, K., Izumikawa, K., Yanagihara, K., Mukae, H.
10.1101/2022.05.23.22275444 — Posted: 2022-05-25
Depressive and anxiety symptoms during the COVID-19 pandemic: A two-year follow-up
Bu, F., Steptoe, A., Fancourt, D.
10.1101/2022.05.24.22275529 — Posted: 2022-05-25
Hemin shows antiviral activity in vitro, possibly through suppression of viral entry mediators.
UNAL, M. A., BITIRIM, C. V., SOMERS, J., SUMMAK, G. Y., BUL BESBINAR, O., KOCAKAYA, E., GURCAN, C., NAZIR, H., Aksoy Ozer, Z. B., OZKAN, S. A., BEREKETOGLU, S., OZKUL, A., DEMIR, E., AKCALI, K. C., YILMAZER, A.
10.1101/2022.05.24.493187 — Posted: 2022-05-25
Initial protection against Omicron in children and adolescents by BNT162b2
Amir, O., Goldberg, Y., Mandel, M., Bar-On, Y. M., Bodenheimer, O., Freedman, L., Ash, N., Alroy-Preis, S., Huppert, A., Milo, R.
10.1101/2022.05.22.22275323 — Posted: 2022-05-25
Humoral Immunity to SARS-CoV-2 and Inferred Protection from Infection in a French Longitudinal Community Cohort
Woudenberg, T., Pinaud, L., Garcia, L., Tondeur, L., Pelleau, S., de Thoisy, A., Donnadieu, F., Backovic, M., Attia, M., Hoze, N., Duru, C., Koffi, A. D., Castelain, S., Ungeheuer, M.-N., Fernandes Pellerin, S., Planas, D., Bruel, T., CAUCHEMEZ, S., Schwarz, O., Fontanet, A., White, M.
10.1101/2022.05.23.22275460 — Posted: 2022-05-25
Diagnostic accuracy of the Panbio COVID-19 Antigen rapid test device for SARS-CoV-2 detection in Kenya, 2021: A field evaluation
Irungu, J. K., Munyua, P., Ochieng, C., Juma, B., Amoth, P., Kuria, F., Kiiru, J., Makayotto, L., Abade, A., Bulterys, M., Hunsperger, E., Emukule, G. O., Onyango, C., Samandari, T., Barr, B. A. T., Akelo, V., Weyenga, H., Munywoki, P. K., Bigogo, G., Otieno, N. A., Kisivuli, J. A., Ochieng, E., Nyaga, R., Hull, N., Herman-Roloff, A., Aman, R.
10.1101/2022.05.23.22275439 — Posted: 2022-05-25
SARS-CoV-2 Booster Effect and Waning Immunity in Hemodialysis Patients
Goggins, E., Sharma, B., Gautam, J., Ma, J. Z., Bowman, B.
10.1101/2022.05.22.22275183 — Posted: 2022-05-25
SARS-CoV-2 NSP3, NSP4 and NSP6 mutations and Epistasis during the pandemic in the world: Evolutionary Trends and Natural Selections in Six Continents
Fooladinezhad, H., Shahidi, M., Mahmanzar, M., Mahdavi, B., Tokhanbigli, S., Mollapour Sisakht, M., Moradi, B., Ganjalikhany, M. R., Rahimian, K., Ganjalikhani-Hakemi, M.
10.1101/2022.05.22.22275422 — Posted: 2022-05-25
Clinical features and burden of post-acute sequelae of SARS-CoV-2 infection in children and adolescents: an exploratory EHR-based cohort study from the RECOVER program
Rao, S., Lee, G. M., Razzaghi, H., Lorman, V., Mejias, A., Pajor, N. M., Thacker, D., Webb, R., Dickinson, K., Bailey, C., Jhaveri, R., Christakis, D. A., Bennett, T. D., Chen, Y., Forrest, C. B.
10.1101/2022.05.24.22275544 — Posted: 2022-05-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).